Technical Analysis for BSX - Boston Scientific Corporation

Grade Last Price % Change Price Change
grade A 37.69 2.39% 0.88
BSX closed up 2.39 percent on Friday, January 18, 2019, on 1.37 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 6

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BSX trend table...

Date Alert Name Type % Chg
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Cup with Handle Other 2.39%
Jan 17 Outside Day Range Expansion 2.39%
Jan 17 Overbought Stochastic Strength 2.39%
Jan 16 Cup with Handle Other 2.92%
Jan 16 Spinning Top Other 2.92%
Jan 16 Narrow Range Bar Range Contraction 2.92%
Jan 16 NR7 Range Contraction 2.92%
Jan 16 Inside Day Range Contraction 2.92%

Older signals for BSX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.
Is BSX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.44
52 Week Low 25.04
Average Volume 7,505,955
200-Day Moving Average 33.9774
50-Day Moving Average 35.7162
20-Day Moving Average 34.8955
10-Day Moving Average 36.034
Average True Range 1.0756
ADX 16.03
+DI 30.7561
-DI 20.8806
Chandelier Exit (Long, 3 ATRs ) 34.5432
Chandelier Exit (Short, 3 ATRs ) 34.7868
Upper Bollinger Band 37.8752
Lower Bollinger Band 31.9158
Percent B (%b) 0.97
BandWidth 17.077847
MACD Line 0.4226
MACD Signal Line 0.0414
MACD Histogram 0.3812
Fundamentals Value
Market Cap 51.72 Billion
Num Shares 1.37 Billion
EPS 0.56
Price-to-Earnings (P/E) Ratio 67.30
Price-to-Sales 4.54
Price-to-Book 5.46
PEG Ratio 2.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.34
Resistance 3 (R3) 39.18 38.48 39.07
Resistance 2 (R2) 38.48 38.06 38.56 38.97
Resistance 1 (R1) 38.08 37.80 38.28 38.24 38.88
Pivot Point 37.38 37.38 37.48 37.46 37.38
Support 1 (S1) 36.98 36.96 37.18 37.14 36.50
Support 2 (S2) 36.28 36.70 36.36 36.41
Support 3 (S3) 35.88 36.28 36.32
Support 4 (S4) 36.04